Traditional Chinese medicine tea for treating psoriasis

Abstract

The invention discloses a traditional Chinese medicine tea for treating psoriasis. The tea consists of the following components: 10-15 parts of saffron, 8-12 parts of Chinese ilex leaves, 4-8 parts ofChinese yams, 2-6 parts of giant knotweed rhizomes, 8-13 parts of dandelions, 6-9 parts of Chinese dates, 2-6 parts of lightyellow sophora roots, 8-13 parts of perilla, 2-7 parts of cogon grass rhizomes, 1-5 parts of divaricate saposhnikovia roots, 5-9 parts of poria cocos, 3-7 parts of pagodatree flower buds, 9-13 parts of chrysanthemums and 35-40 parts of black tea. According to the invention,the saffron and the giant knotweed rhizomes are used for promoting blood circulation and removing blood stasis; the Chinese ilex leaves, the cogon grass rhizomes and the pagodatree flower buds are used for cooling blood to stop bleeding; the lightyellow sophora roots and the divaricate saposhnikovia roots are used for dispelling pathogenic wind and relieving itching; the dandelions and the chrysanthemums are used for clearing away heat and toxic materials; the Chinese yams, the Chinese dates, the perilla and the poria cocos are added to play a role in tonifying spleen and kidney, tonifying qi,calming nerves, inducing diuresis and moistening intestines, and are capable of enhancing the physique of patients and improving the immunity; and the black tea matches with the above materials, andcan remove the bitter and astringent taste of traditional Chinese medicines; and the tea is prepared into tea bags which are convenient to use. The product is low in cost, simple to prepare and convenient to use, and has the effects of treating diseases, strengthening body constitution and protecting health.

Description

technical field [0001] The invention relates to the field of health-care tea, in particular to a traditional Chinese medicine tea for treating psoriasis. Background technique [0002] Psoriasis is commonly called as psoriasis, is a kind of chronic inflammatory skin disease, and the course of disease is longer, has easy recurrence tendency, and the case that has almost does not heal all one's life. The onset of the disease is mainly in young adults, and it has a greater impact on the patient's physical health and mental status. The clinical manifestations are mainly erythema and scales, and the whole body can be affected. The scalp and the extensor sides of the extremities are more common, and they are mostly aggravated in winter. There is no specific therapy for this disease in modern medicine, and appropriate symptomatic treatment can control symptoms. The treatment methods are usually external application and oral administration. External application can use vitamin D3 a...

AI Technical Summary

Problems solved by technology

The treatment methods are usually external application and oral administration. External application can use vitamin D3 analogues, glucocorticoids, retinoic acid, anthralin, etc., which can improve symptoms to a certain extent, but vitamin D3 analogues can cause hypercalcemia. Glucocorticoids will cause skin lesions, and there will be a "rebound" phenomenon after stopping the drug. Retinoic acid is slow to take effect and cannot be used for pregnant women. Anthralin cannot be used on the face and intertriginous areas; oral administration mainly includes methotrexate Methotrexate, retinoic acid, immunotherapy and biological agent therapy, etc., methotrexate can damage the liver and kidney, and should be used with caution for active infectious diseases, alcoholism, immunodeficiency and other serious diseases. Long-term use of retinoic acid Elevated blood lipids, liver damage, etc. may occur. It is expensive, and there are adverse reactions in immunotherapy and biological agent therapy, and it is still immature